LTRN (STOCKS)
Lantern Pharma Inc. Common Stock
$3.690000
-0.190000 (-4.90%)
Prev close: $3.880000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Panna L. Sharma
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $41.71M
- Employees
- 24
- P/E (TTM)
- -2.55
- P/B (TTM)
- 12.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.30 | $-0.37 | +0.0672 | +18.30% |
|
Dec 2025 (Q4)
|
$-0.36 | $-0.47 | +0.1092 | +23.27% |
|
Sep 2025 (Q3)
|
$-0.39 | $-0.48 | +0.0894 | +18.65% |
|
Jun 2025 (Q2)
|
$-0.40 | $-0.49 | +0.0947 | +19.14% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $16.61M |
| Depreciation and Amortization | $16.56K |
| Research and Development | $9.98M |
| Other Operating Expenses | $6.62M |
| Operating Income/Loss | -$16.61M |
| Income/Loss From Continuing Operations After Tax | -$15.91M |
| Income/Loss From Continuing Operations Before Tax | -$15.91M |
| Net Income/Loss | -$15.91M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$15.91M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.91M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.45 |
| Diluted Earnings Per Share | -$1.45 |
| Basic Average Shares | 11,366,480 |
| Diluted Average Shares | 11,366,480 |
| Assets | $7.22M |
| Current Assets | $7.06M |
| Noncurrent Assets | $165.81K |
| Fixed Assets | $28.02K |
| Other Non-current Assets | $137.79K |
| Liabilities | $3.78M |
| Current Liabilities | $3.78M |
| Noncurrent Liabilities | $0.00 |
| Equity | $3.45M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.45M |
| Liabilities And Equity | $7.22M |
| Net Cash Flow From Operating Activities | -$15.07M |
| Net Cash Flow From Operating Activities, Continuing | -$15.07M |
| Net Cash Flow From Investing Activities | $12.07M |
| Net Cash Flow From Investing Activities, Continuing | $12.07M |
| Net Cash Flow From Financing Activities | -$115.41K |
| Net Cash Flow From Financing Activities, Continuing | -$115.41K |
| Net Cash Flow | -$3.12M |
| Net Cash Flow, Continuing | -$3.12M |
| Comprehensive Income/Loss | -$16.08M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$16.08M |
| Other Comprehensive Income/Loss | -$167.37K |